CredibleMeds Status
Published by Azcert Inc This CredibleMeds Mobile App supports the CredibleMeds.org website which
maintains and posts lists of drugs in categories that reflect their ability to
prolong the QT interval on the electrocardiogram and/or cause the
life-threatening heart arrhythmia, torsades de pointes (TdP).
Are you having issues? Select the issue you are having below and provide feedback to CredibleMeds.
problems reported in the last 24 hours
Reported Issues: 0 Comments
No reports yet! Be the first to report an issue.
Common dislikes about CredibleMeds app
- Needs to be updated more frequently
- Unable to search by name brand rather than active ingredients
- Some medications do not show up when searched for
Have a Problem with CredibleMeds Mobile? Report Issue
Leave a comment:
Common CredibleMeds Problems & Solutions. Troubleshooting Guide
Complete guide to troubleshoot CredibleMeds app on iOS and Android devices. Solve all CredibleMeds app problems, errors, connection issues, installation problems and crashes.
Table of Contents:
Some issues cannot be easily resolved through online tutorials or self help. So we made it easy to get in contact with the support team at Azcert Inc, developers of CredibleMeds.
100% Contact Match
Developer: Azcert Inc
E-Mail: [email protected]
Website: Visit CredibleMeds Website
This this app Mobile App supports the this app. org website which maintains and posts lists of drugs in categories that reflect their ability to prolong the QT interval on the electrocardiogram and/or cause the life-threatening heart arrhythmia, torsades de pointes (TdP). The this app Mobile App was developed for patients with Congenital Long QT Syndrome, healthcare professionals and research scientists in order to provide them with ready access to the most up-to-date version of the this app lists of drugs. For healthcare professionals and research scientists, the QTdrugs Lists can be used to identify which drugs can cause QT prolongation or TdP. CredibleMeds also provides background information on the categories of drug risk and explains the relationship between QT prolongation and TdP. For patients with Congenital Long QT Syndrome, the drugs and risk categories are described and presented separately as the Drugs to Avoid in cLQTS.
